Lista de obras -

Analysis of predictive and prognostic factors in 290 patients treated with oncolytic adenoviruses.

artículo científico publicado en 2015

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

artículo científico publicado en 2013

Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues

artículo científico publicado en 2015

Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors

artículo científico publicado en 2014

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

artículo científico publicado en 2015

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

artículo científico publicado en 2013

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy ⬇️

artículo científico publicado en 2015

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus

artículo científico publicado en 2011

In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

artículo científico publicado en 2011

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

artículo científico publicado en 2011

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.

artículo científico publicado en 2018

Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer

artículo científico publicado en 2016

Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors

artículo científico publicado en 2010

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients

artículo científico publicado en 2010

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

artículo científico publicado en 2010

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

artículo científico publicado en 2013

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

artículo científico publicado en 2012

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

artículo científico publicado en 2015

PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease

artículo científico publicado en 2017

Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy

artículo científico publicado en 2016

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors

artículo científico publicado en 2010

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

artículo científico publicado en 2014

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

artículo científico publicado en 2015

Structural Immaturity of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling

artículo científico publicado en 2018

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

artículo científico publicado en 2011

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

artículo científico publicado en 2010

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

artículo científico publicado en 2015

[(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancer

artículo científico publicado en 2013

Lista de obras de

Analysis of predictive and prognostic factors in 290 patients treated with oncolytic adenoviruses.

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues

Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy ⬇️

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus

In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.

Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer

Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease

Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

Structural Immaturity of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

[(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancer